Oncology Clinical Trials in Richmond, VA
As of August 2026, 123 paid clinical trials are recruiting for Oncology in Richmond, Virginia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
123 clinical trials for Oncology
·Clear filters·Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Stratagen Quantitative Prostate MRI Platform Pilot Study
Top Research Study Locations in Richmond
Researchers run research studies in Richmond, VA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Virginia Commonwealth University | Heart Failure, Myotonic Dystrophy 1, Violence | 161 |
| VCU Massey Comprehensive Cancer Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Stage III Laryngeal Cancer AJCC v8 | 107 |
| VCU Massey Cancer Center at Stony Point | Anatomic Stage II Breast Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8, Lung Non-Small Cell Carcinoma | 51 |
| Virginia Cancer Institute | Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Anatomic Stage I Breast Cancer AJCC v8 | 23 |
| Bon Secours Saint Mary's Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 23 |
| Bon Secours Cancer Institute at Reynolds Crossing | Stage IVA Prostate Cancer AJCC v8, Malignant Solid Neoplasm, Stage III Prostate Cancer AJCC v8 | 18 |
| Bon Secours Richmond Community Hospital | Breast Cancer, Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia | 12 |
| Clinical Research Partners, LLC | Pneumococcal Disease, Asthma, Celiac Disease | 12 |
| VCU Medical Center | Acute Decompensated Heart Failure, Chemotherapy Induced Peripheral Neuropathy (CIPN), Chronic Thromboembolic Pulmonary Hypertension | 9 |
| Virginia Commonwealth University Massey Cancer Center | B-cell Malignancy, Cervical Cancer, Chemotherapy-induced Peripheral Neuropathy | 9 |
| GSK Investigational Site | Chickenpox, Colonic Neoplasms, Irritable Bowel Syndrome | 8 |
| Virginia Commonwealth University Medical Center | Adolescent - Emotional Problem, Bipolar Disorder, Bipolar I Disorder | 8 |
| Richmond VA Medical Center | Colorectal Neoplasms, Dementia Alzheimer Type, Dementia Associated With Cerebrovascular Disease | 7 |
| Hunter Holmes McGuire VA Medical Center, Richmond, VA | Acute Kidney Injury, Atherosclerosis, Cardiovascular Disease | 6 |
| National Clin Res Inc. | Obesity, Overweight, Diabetes Mellitus | 6 |
| Richmond VA Medical Center, Richmond, VA | Alcohol Use Disorder (AUD), Cirrhosis, Epilepsy | 6 |
| Virginia Commonwealth University/Massey Cancer Center | Non-Hodgkin Lymphoma, Stage IVB Prostate Cancer AJCC v8, Breast Carcinoma | 6 |
| OvationLab | Gastrointestinal, Biological Aging, Detoxification | 5 |
| VCU Massey Cancer Center | Cutaneous Melanoma, Stage II, Metastatic Head-and-neck Squamous-cell Carcinoma, Non-small Cell Lung Cancer | 5 |
| Clinical Trial Site | Advanced Hepatocellular Carcinoma, High Cardiovascular Risk, High Risk Cardiovascular Disease | 4 |
| Children's Hospital of Richmond at VCU | Becker Muscular Dystrophy, Cardiac Arrest, Cardiac Arrest (CA) | 4 |
| Henrico Doctor's Hospital | Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma | 4 |
| Pulmonary Associates of Richmond, Inc. | Interstitial Lung Disease, Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis | 4 |
| Virginia Commonwealth University (VCU) | Aortic Aneurysm, Abdominal, LOPD, Myotonic Dystrophy Type 1 (DM1) | 4 |
| Virginia Commonwealth University Health System | COPD, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis Lung | 4 |
Active & Upcoming Studies in Richmond (2026)
Recruiting trials in Richmond grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (210 active studies)
- A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma · Phase 3 · AbbVie
- Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma · Phase 1 · Virginia Commonwealth University
Cardiovascular (45 active studies)
- CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA) · VA Office of Research and Development
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Diabetes & metabolic (24 active studies)
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
- AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight · Phase 3 · Novo Nordisk A/S
Neurology & pain (21 active studies)
- Bedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury · Virginia Commonwealth University
- Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD) · Virginia Commonwealth University
Mental health & behavior (16 active studies)
- QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428 · Veterans Recovery Network Inc.
- Enhancing Addiction Treatment Through Psychoeducation · Virginia Commonwealth University
Vaccines (6 active studies)
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age · Phase 3 · GlaxoSmithKline
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age · Phase 3 · GlaxoSmithKline
Pediatric (5 active studies)
- Children's Bipolar Network Treatment Trial I · University of California, Los Angeles
- Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS · Phase 2, Phase 3 · Nationwide Children's Hospital
HIV / STI (4 active studies)
- A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV · Phase 2 · Naga P. Chalasani
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection · Phase 1 · GigaGen, Inc.
Eye & vision (1 active study)
Common conditions studied in Richmond
- Heart Failure (12 active studies)
- Obesity (11 active studies)
- Breast Cancer (10 active studies)
- Acute Myeloid Leukemia (9 active studies)
- Malignant Solid Neoplasm (7 active studies)
- Non-Small Cell Lung Cancer (6 active studies)
Leading research sponsors in Richmond
- Virginia Commonwealth University
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Richmond?
There are approximately 583 recruiting clinical trials in Richmond, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Richmond pay participants?
Most recruiting trials in Richmond compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Richmond?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Richmond?
The most common conditions under active study in Richmond include Heart Failure (12), Obesity (11), Breast Cancer (10), Acute Myeloid Leukemia (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Richmond?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Richmond on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Richmond?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Richmond?
Recruiting research sites in Richmond include Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, VCU Massey Cancer Center at Stony Point, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Richmond right now?
The largest active categories in Richmond are Cancer & tumors (210), Cardiovascular (45), Diabetes & metabolic (24). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.